rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sara Zaknoen

Director

Company insider

Files Form 4 as: Director, aTyr Pharma.

In numbers

Trades disclosed
9
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
21 May 2021
Last trade
11 May 2026
Last filed
13 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ATYR aTyr PharmaDirector · Biotechnology · last 11 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
11 May 2026filed 13 May 2026ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
11 May 2026filed 13 May 2026ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
1 May 2025filed 2 May 2025ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
22 May 2024filed 23 May 2024ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—24,000 at $0.00filing
17 May 2023filed 19 May 2023ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—12,000 at $0.00filing
26 Apr 2023filed 28 Apr 2023ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—6,000 at $0.00filing
26 Apr 2023filed 28 Apr 2023ATYR aTyr PharmaBiotechnologySEC FORM 4 Code M—6,000filing
26 Apr 2022filed 28 Apr 2022ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—6,000 at $0.00filing
21 May 2021filed 25 May 2021ATYR aTyr Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—2,285 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Brandon YarasChief Financial Officer · Chief Financial Officer at aTYR PHARMA, filing Form 4 there in the last year
Paul SchimmelDirector · Director at aTYR PHARMA, filing Form 4 there in the last year
Jane A. GrossDirector · Director at aTYR PHARMA, filing Form 4 there in the last year
Svetlana LucasDirector · Director at aTYR PHARMA, filing Form 4 there in the last year
Eric BenevichChief Commercial Officer · Director at aTYR PHARMA, filing Form 4 there in the last year